These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6905641)

  • 21. Hypertension in adult onset diabetes mellitus: abnormal renal hemodynamics and endogenous vasoregulatory factors.
    Olshan AR; O'Connor DT; Cohen IM; Stone RA
    Am J Kidney Dis; 1982 Sep; 2(2):271-80. PubMed ID: 6751073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Fed Proc; 1976 Feb; 35(2):203-6. PubMed ID: 1248655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of sodium and potassium loading on urinary kallikrein-like activity in young patients with borderline hypertension.
    Ando K; Ito Y; Noda H; Fujita T
    Jpn Circ J; 1985 Nov; 49(11):1151-8. PubMed ID: 3854057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary kallikrein excretion in spontaneously hypertensive rats.
    Geller RG; Margolius HS; Pisano JJ; Keiser HR
    Circ Res; 1975 Jun; 36(6 Suppl 1):103-6. PubMed ID: 1132073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary kallikrein excretion in chronic renal failure: relationship to blood pressure and the acute effect of captopril.
    Cumming AD; Lambie AT
    Ren Fail; 1987-1988; 10(3-4):161-7. PubMed ID: 3332725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary kallikrein in rats bred for susceptibility and resistance to the hypertensive effect of salt and in New Zealand genetically hypertensive rats.
    Carretero OA; Scicli AG; Piwonska A; Koch J
    Mayo Clin Proc; 1977 Jul; 52(7):465-7. PubMed ID: 875472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of MK-421 in rats. Role of the renal kallikrein-kinin system.
    Yasujima M; Abe K; Tanno M; Kasai Y; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Hypertension; 1984; 6(2 Pt 1):229-35. PubMed ID: 6327517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
    Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
    [No Abstract]   [Full Text] [Related]  

  • 30. Defect in kallikrein-kinin-system in essential hypertension and reduction of blood pressure by orally given kallikrein.
    Overlack A; Stumpe KO; Zywzock W; Ressel C; Drück F
    Adv Exp Med Biol; 1979; 120B():539-47. PubMed ID: 517248
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary prostaglandins and kallikrein in essential hypertension.
    Weber PC; Scherer B; Held E; Siess W; Stoffel H
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():259s-261s. PubMed ID: 396075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure sensitivity to salt in rats with low urinary kallikrein excretion.
    Madeddu P; Varoni MV; Demontis MP; Pinna-Parpaglia P; Glorioso N; Anania V
    Immunopharmacology; 1996 Jun; 33(1-3):301-4. PubMed ID: 8856169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
    Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
    J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
    Distler A; Wolff HP
    Klin Wochenschr; 1979 Oct; 57(19):1037-45. PubMed ID: 392177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary kallikrein excretion is low in malignant essential hypertension.
    Hilme E; Herlitz H; Gyzander E; Hansson L
    J Hypertens; 1992 Aug; 10(8):869-74. PubMed ID: 1325521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
    Seino M; Abe K; Sakurai Y; Irokawa N; Yasujima M; Chiba S; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1977 Feb; 121(2):111-9. PubMed ID: 847738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
    Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
    Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renal kallikrein-kinin system and the regulation of salt and water excretion.
    Mills IH; Macfarlane NA; Ward PE; Obika LF
    Fed Proc; 1976 Feb; 35(2):181-8. PubMed ID: 765162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
    Overlack A; Stumpe KO; Müller HM; Kolloch R; Higuchi M
    Klin Wochenschr; 1982 Oct; 60(19):1223-8. PubMed ID: 6183482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.